3E51 image
Entry Detail
PDB ID:
3E51
Keywords:
Title:
Crystal structure of HCV NS5B polymerase with a novel pyridazinone inhibitor
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2008-08-12
Release Date:
2009-08-18
Method Details:
Experimental Method:
Resolution:
1.90 Å
R-Value Free:
0.27
R-Value Work:
0.22
R-Value Observed:
0.22
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:RNA-directed RNA polymerase
Mutations:R544Q
Chain IDs:A, B
Chain Length:578
Number of Molecules:2
Biological Source:Hepatitis C virus (isolate BK)
Ligand Molecules
Primary Citation
Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda(6)-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 5: Exploration of pyridazinones containing 6-amino-substituents.
Bioorg.Med.Chem.Lett. 18 5635 5639 (2008)
PMID: 18796353 DOI: 10.1016/j.bmcl.2008.08.094

Abstact

The synthesis of 4-(1',1'-dioxo-1',4'-dihydro-1'lambda(6)-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones bearing 6-amino substituents as potent inhibitors of the HCV RNA-dependent RNA polymerase (NS5B) is described. Several of these agents also display potent antiviral activity in cell culture experiments (EC(50)<0.10 microM). In vitro DMPK data (microsome t(1/2), Caco-2 P(app)) for many of the compounds are also disclosed, and a crystal structure of a representative inhibitor complexed with the NS5B protein is discussed.

Legend

Protein

Chemical

Disease

Primary Citation of related structures